Expertise
Depth across capability building, governance and scientific engagement
Pillar One
Capability Building
Dr Telang has built and developed medical teams comprising medical advisors, MSLs, medical operations and regulatory professionals. She has led recruitment, onboarding, coaching and career development across Medical Affairs and cross-functional teams.
Training sessions delivered
Reps trained per cycle meeting
Faculty developed
HCPs reached via faculty
- Delivering 100+ scientific, therapeutic-area and product-training sessions for internal medical and commercial teams
- Training sales teams at scale, at quarterly cycle meetings with about 200–400 representatives per cycle meeting
- Designing induction programmes of 4–7 days for new teams and specialised therapeutic-area teams
- Building and developing MSL teams, including competency frameworks, stakeholder-engagement models, KPI tracking and coaching
- Supporting onboarding, mentoring and career transitions from MSL to Medical Advisor and leadership roles
- Establishing scientific communication and internal-speaker development programmes
- Leading faculty-development models that enabled 250 trained faculty members to support education reaching 1000+ HCPs
- Conducting regular one-to-one coaching and mentoring to develop team capability and accountability
Pillar Two
Governance Expertise
Dr Telang brings extensive experience in establishing compliant, scalable and audit-ready Medical Affairs processes for pharmaceutical organisations.
CDSCO SEC presentations
Governance domains covered
- Medical Affairs strategy and operational governance across portfolios
- Review and approval of promotional and scientific materials across therapy areas
- Adaptation of global SOPs and processes for Indian requirements
- Implementation of medical education and medical-information workflows
- UCPMP-compliant scientific communication and clear separation of medical and commercial activities
- Governance of advisory boards, investigator and KOL engagement, research grants, independent medical education and congress activities
- Regulatory scientific engagement, including 50+ Subject Expert Committee regulatory presentations at CDSCO office
- Prescribing information updates, safety communications and pharmacovigilance collaboration
- Audit-readiness monitoring, documentation trails, approval workflows and CAPA oversight
- Crisis-management leadership during product withdrawals, regulatory communication and relaunches
Pillar Three
Strategic Scientific Engagement Expertise
Dr Telang has led scientific engagement across the product lifecycle at Cipla, Merck Serono, MSD, Janssen, GSK and Sanofi/Opella Healthcare. Her experience spans critical care, respiratory, immunology, cardiovascular, nephrology, gastroenterology, neurology, endocrinology, consumer healthcare and other therapy areas. She has engaged a broad network of hundreds of KOLs across disciplines including respiratory medicine, rheumatology, dermatology, gastroenterology, nephrology, cardiology, endocrinology, paediatrics, gynaecology, neurology and critical care.
Pre-launch Initiatives
- Defining unmet medical needs and local scientific rationale for new therapies
- Mapping and engaging KOLs, associations and multidisciplinary stakeholders
- Developing medical strategies, evidence-generation plans and disease-awareness initiatives for multiple pre-launch assets
- Conducting advisory boards to refine place-in-therapy, patient-pathway and evidence-generation plans
- Supporting protocol development, site feasibility, investigator identification and scientific training for clinical, Phase IV and real-world evidence studies
- Preparing scientific presentations and engagement with regulatory authorities
- Developing launch-ready scientific resources, including dossiers, monographs, prescribing information, scientific slide decks and internal training materials
Launch Initiatives
Dr Telang has contributed to the launch of products across specialty medicines and consumer-healthcare portfolios.
Advisory boards delivered
- Designing and executing medical launch strategies
- Training internal teams, HCPs and specialist audiences at national and zonal meetings
- Building compliant KOL-engagement and scientific-speaker programmes
- Delivering 20+ advisory boards and numerous scientific forums across therapy areas
- Supporting international speaker programmes and cross-specialty meetings
- Translating global evidence into locally relevant, balanced scientific exchange
- Supporting scientific differentiation through evidence summaries, guideline alignment, disease-state education and place-in-therapy communication
- Partnering with Commercial, Regulatory, Clinical, Pharmacovigilance and Compliance teams for coordinated, compliant execution
Post-launch Initiatives
Dr Telang has led or supported multiple Phase IV, real-world evidence, post-authorisation safety and physician-insight programmes.
Accredited CMEs led
- Supporting evidence-generation programmes from protocol development through site initiation, recruitment, monitoring, data interpretation, publication and scientific dissemination
- Leading medical-education initiatives including 350 accredited CMEs nationwide
- Measuring medical-education impact through participant feedback, insight capture and NPS-based evaluation
- Managing international speaker programmes, cross-specialty forums and national congress scientific sessions
- Generating KOL insights to refine medical strategy and address ongoing unmet patient needs
- Creating scientific newsletters, medical-information systems, HCP-engagement platforms, podcasts and omnichannel medical initiatives
- Supporting publication, abstract and congress dissemination of scientific evidence
- Maintaining lifecycle governance through safety communication, label updates, regulatory engagement and continuous medical-strategy refinement
Expertise Snapshot
Scientific engagement, illustrated
